About UPM Biomedicals


UPM Biomedicals is the forerunner in producing high quality nanofibrillar cellulose for medical and life science applications. More than 300 patents protect the existing and future products that rely on the Finnish birch pulp. We actively collaborate with universities, research centers and key industrial partners on future innovations and products in the field of high throughput drug screening, personalized medicine, advanced cell therapies, 3D bioprinting, tissue engineering and advanced wound care.

We are part of UPM, the Biofore Company that creates value from renewable and recyclable materials. In 2020, UPM’s sales were approximately EUR 8.6 billion. UPM has production plants in 13 countries and a global sales network. UPM employs approximately 18,000 employees worldwide. UPM shares are listed on the NASDAQ OMX Helsinki stock exchange. At the end of 2020, UPM had approximately 113,000 shareholders.

Read more about UPM


Advancing bio-innovations from renewable resources

Our patented 3D hydrogel technology is used in a wide range of biomedical applications.

1. Tree

2. Logs

3. Fibres

Nature has provided the perfect source of raw materials from which we have developed our ready to use room temperature stable products for the biomedical area.

Pulp fibres processed to nanoscale diameter can be easily modified into various forms, such as hydrogels, films and aerogels. These physical and mechanical properties have made nanofibrillar cellulose (NFC) useful as a drug and cell carrier, cell scaffold and composite material. Furthermore, the potential of NFC for wound treatment applications has also been demonstrated.


Our products utilizes these unique characteristics of nanofibrillar cellulose.

Biocompatibility, high hydrophilic potential and the nanocellulose fibre scaffold provide cells with an environment that mimics the extracellular matrix (ECM) supporting cell growth and differentiation. High water content ensures easy diffusion of nutrients and metabolites and allows our products ton be mixed easily with cells, media or drugs.

Shear thinning properties ensures easy dispensing for HTS assays, 3D printing or injection for drug release or organ-on-a-chip models.

Controllable mechanical properties ensures that the hydrogels are suitable for a wide range of cells, tissues and applications.


Commitment to sustainability

Well-maintained commercial forests act as a carbon sink to help mitigate the effects of climate change and provide renewable resources. We source raw material from sustainably-managed forests with legal logging operations and replant all harvested areas to uphold biodiversity. To take the new steps towards a future beyond fossils, we actively expand and accelerate the use of renewable resources to replace fossil raw materials and advance bio-innovations.

Sustainability is the only solid foundation for long term value creation

We are challenged by ever increasing resource scarcity, climate change, tightening regulation and requirements by conscious consumers. We all share the same thinking; sustainability is the only solid foundation to build business on. 

In 2021 UPM strongly focus on promoting our ambitious climate agenda and the climate-positive forestry as an important part of it. We also focus on supporting the UN Global Compact Sustainable Development Goals through our responsible operations and sustainable and safe solutions. 

Read more